FOX CHASE CANCER CENTER
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1904-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.foxchase.org
nCLE For Diagnosis Of Peripheral Lung Nodules By Robotic Navigational Bronchoscopy
- Conditions
- Diagnosis of Peripheral Lung Nodules
- Interventions
- Device: Images acquired by needle-based Confocal Laser Endomicroscopy (nCLE)
- First Posted Date
- 2020-06-22
- Last Posted Date
- 2023-02-08
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 25
- Registration Number
- NCT04441749
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
🇳🇱Amsterdam University Medical Center, Amsterdam, AZ, Netherlands
Phase I Study in Advanced Malignancies With 5-ALA
- First Posted Date
- 2020-05-11
- Last Posted Date
- 2024-08-26
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 130
- Registration Number
- NCT04381806
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Atorvastatin ± Aspirin in Lynch Syndrome Syndrome
- Conditions
- Lynch Syndrome
- Interventions
- First Posted Date
- 2020-05-08
- Last Posted Date
- 2025-02-26
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 46
- Registration Number
- NCT04379999
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Technology and Health Communication in Improving Health Outcomes in Patients Scheduled for Mammography
- Conditions
- Female Breast CarcinomaHealthy Subject
- Interventions
- Other: Questionnaire AdministrationBehavioral: Telephone-Based Intervention
- First Posted Date
- 2020-03-02
- Last Posted Date
- 2020-03-02
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 160
- Registration Number
- NCT04290585
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Liver Cancer Community Education
- Conditions
- Liver Cancer
- Interventions
- Behavioral: LIVE-R Life Education
- First Posted Date
- 2020-02-17
- Last Posted Date
- 2025-01-08
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 67
- Registration Number
- NCT04272619
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Clinician Communication About Sexual Health
- Conditions
- Breast Cancer
- Interventions
- Behavioral: iShare
- First Posted Date
- 2020-02-10
- Last Posted Date
- 2022-12-23
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 32
- Registration Number
- NCT04262219
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Study to Assess TOPO2A as a Biomarker for Sensitivity to Doxorubicin/Doxil in Soft Tissue Sarcoma
- First Posted Date
- 2019-08-14
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 24
- Registration Number
- NCT04055753
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Efficacy of Topical Mitomycin C for Complex Benign Esophageal Anastomotic Strictures
- Conditions
- Esophageal StenosisAnastomotic Stenosis
- Interventions
- Other: Control
- First Posted Date
- 2019-07-30
- Last Posted Date
- 2022-04-11
- Lead Sponsor
- Fox Chase Cancer Center
- Registration Number
- NCT04037072
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Utility of CAML as Diagnostic for Early Stage Lung Cancer
- Conditions
- Pulmonary Nodule, MultiplePulmonary Nodule, Solitary
- First Posted Date
- 2019-06-20
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 200
- Registration Number
- NCT03992183
- Locations
- 🇺🇸
Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania, United States
🇺🇸Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Coping Together After Breast Cancer
- Conditions
- Breast Cancer
- Interventions
- Behavioral: Intimacy EnhancementBehavioral: Living Healthy Together
- First Posted Date
- 2019-04-29
- Last Posted Date
- 2024-07-11
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 240
- Registration Number
- NCT03930797
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States